comparemela.com

Latest Breaking News On - Monsoon communications - Page 9 : comparemela.com

AVITA Medical Reports Second Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, Aug. 11, 2022 AVITA Medical, Inc. , a regenerative medicine company that is developing and commercializing a technology platform that enables. | August 11, 2022

United statesRudi michelsonMike perryChristy curranDrug administrationSam brown incExchange commissionMonsoon communicationsJapan pharmaceuticalsGlobenewswire incQuarter highlightsRecent updatesChief executiveConference callEastern standard timeChief financial officer

Opthea Presentation at The Ret - GuruFocus com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

University of southern californiaUnited statesFort lauderdaleSam martinDavid boyerRudi michelsonSilvana guerci lenaMegan baldwinRetina world congressKeck school of medicineInvestment in biotechnology companiesVitreous associates medical groupCompany media enquiriesMonsoon communicationsOpthea limitedAge related macular

AVITA Medical Reports First Quarter 2022 Financial Results

VALENCIA, Calif. and MELBOURNE, Australia, May 12, 2022 (GLOBE NEWSWIRE) AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative.

United statesRudi michelsonChristy curranMike perryDrug administrationSam brown incExchange commissionMonsoon communicationsDevices agencyJapan pharmaceuticalsRecent updatesAutologous cell harvesting deviceMedical devices agencyChief executiveConference callThursday may

CLINUVEL progresses vitiligo treatment program

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesRudi michelsonLinda tengEuropean unionMonsoon communicationsDrug administrationJournal of the american academy dermatologyNorth americaNorth american operationsInstitutional review boardRandomized multicenterAmerican academyInvestor relationsMalcolm bullStreet melbourneGlobe newswire

CLINUVEL progresses vitiligo treatment program - Press Release

MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in

United statesRudi michelsonLinda tengEuropean unionMonsoon communicationsDrug administrationJournal of the american academy dermatologyNorth americaNorth american operationsInstitutional review boardRandomized multicenterAmerican academyInvestor relationsMalcolm bull

vimarsana © 2020. All Rights Reserved.